Loss of serum HBV DNA and HBeAg and seroconversion following short-term (12 weeks) adefovir dipivoxil therapy in chronic hepatitis B: two placebo-controlled phase II studies.
1998
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
53
Citations
NaN
KQI